Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:35 PM EDT

Kamada (KMDA) Operating Expenses (2012 - 2026)

Kamada's (KMDA) quarterly Operating Expenses came in at -$13.0 million in Q2 2026, down 9.27% on a YoY basis from -$14.3 million in Q2 2025, and down 6.53% quarter-over-quarter from -$12.2 million in Q1 2026.

Analysis

Kamada (KMDA) Operating Expenses (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Operating Expenses for 15 consecutive years, with -$13.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Expenses fell 9.27% year-over-year to -$13.0 million; the trailing twelve-month figure through Jun 2026 stood at -$5.3 million (up 79.85% YoY), and the FY2025 full-year result was -$50.2 million, down 213.76% from the prior year.
  • Operating Expenses fell to -$13.0 million in Q2 2026 per KMDA's latest filing, from -$12.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $12.3 million in Q4 2025 and bottomed at -$13.0 million in Q2 2026.
  • Historically, Operating Expenses has averaged $505888.9 across 5 years, with a median of $6.5 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Operating Expenses sank 266.08% in 2023, then surged 188.58% in 2024.
  • Over 5 years, Operating Expenses stood at $9.3 million in 2022, then slumped by 224.78% to -$11.6 million in 2023, then soared by 188.58% to $10.3 million in 2024, then rose by 19.69% to $12.3 million in 2025, then tumbled by 205.03% to -$13.0 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered -$13.0 million, -$12.2 million, and $12.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Amgen 211.77 Bn 197.79 Bn 7.24 Bn 6.54 Bn
2 Gilead Sciences 181.13 Bn 177.95 Bn 6.22 Bn 18.20 Bn
3 Vertex Pharmaceuticals 132.24 Bn 124.39 Bn 2.84 Bn 2.09 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.89 Bn 3.93 Bn 3.00 Bn
5 Argenx Se 61.56 Bn 56.38 Bn 1.37 Bn -1.05 Bn
6 Moderna 54.38 Bn 49.24 Bn 52.00 Mn 960.00 Mn
7 Alnylam Pharmaceuticals 34.44 Bn 31.13 Bn 992.69 Mn 1.06 Bn
8 Biogen 31.17 Bn 29.89 Bn 1.96 Bn 2.60 Bn
9 Roivant Sciences 30.12 Bn 30.12 Bn 1.16 Mn 367.83 Mn
10 Kamada 473.28 Mn 403.14 Mn 22.47 Mn -12.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.96 Mn
Mar 31, 2026 -12.16 Mn
Dec 31, 2025 12.34 Mn
Sep 30, 2025 7.46 Mn
Jun 30, 2025 -11.86 Mn
Mar 31, 2025 -12.95 Mn
Dec 31, 2024 10.31 Mn
Sep 30, 2024 -11.94 Mn
Jun 30, 2024 8.58 Mn
Mar 31, 2024 8.08 Mn
Dec 31, 2023 -11.64 Mn
Sep 30, 2023 -10.44 Mn
Jun 30, 2023 7.77 Mn
Mar 31, 2023 6.65 Mn
Dec 31, 2022 9.33 Mn
Sep 30, 2022 6.28 Mn
Jun 30, 2022 5.95 Mn
Mar 31, 2022 10.31 Mn
Dec 31, 2021 9.28 Mn
Sep 30, 2021 5.24 Mn